The recommended dosage for RESCRIPTOR Tablets is 400 mg (four 100 mg or two 200
mg tablets) three times daily. RESCRIPTOR should be used in combination with
other antiretroviral therapy. The complete prescribing information for other
antiretroviral agents should be consulted for information on dosage and
The 100 mg RESCRIPTOR Tablets may be dispersed in water prior to consumption. To
prepare a dispersion, add four 100 mg RESCRIPTOR Tablets to at least 3 ounces of
water, allow to stand for a few minutes, and then stir until a uniform
dispersion occurs. The dispersion should be consumed promptly. The glass should
be rinsed with water and the rinse swallowed to insure the entire dose is
consumed. The 200 mg tablets should be taken as intact tablets, because they are
not readily dispersed in water. Note: The 200 mg tablets are approximately
one-third smaller in size than the 100 mg tablets.
RESCRIPTOR Tablets may be administered with or without food. Patients with
achlorhydria should take RESCRIPTOR with an acidic beverage (e.g., orange or
cranberry juice). However, the effect of an acidic beverage on the absorption of
delavirdine in patients with achlorhydria has not been investigated.
Patients taking both RESCRIPTOR and antacids should be advised to take them at
least one hour apart.
No adjustment required.
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read